U.S. HOUSE OF REPRESENTATIVES SUPPORTS $20 MILLION FOR PANCREATIC CANCER RESEARCH FUNDING
LOS ANGELES, Sept. 29, 2023 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, is thrilled that the U.S. House of Representatives approved an amendment to the Defense Appropriations Bill, increasing funding for the dedicated Pancreatic Cancer Research Program at the Department of Defense (DoD) from $15 to $20 million for the new fiscal year in their version of the bill. In order for this funding increase to get enacted into law, the Senate will need to advance their version of the bill and the increase will need to be kept intact throughout conference negotiations between both chambers.
- With Leadership from Pancreatic Cancer Action Network (PanCAN) Champions in Congress, House Defense Appropriations Bill Passes with Increase to Pancreatic Cancer Research Program at Department of Defense
LOS ANGELES, Sept. 29, 2023 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, is thrilled that the U.S. House of Representatives approved an amendment to the Defense Appropriations Bill, increasing funding for the dedicated Pancreatic Cancer Research Program at the Department of Defense (DoD) from $15 to $20 million for the new fiscal year in their version of the bill. - As a result of PanCAN's ongoing advocacy efforts, the House Defense Appropriations committee included $15 million for the Pancreatic Cancer Research Program when the Fiscal Year (FY) 24 Defense Appropriations Act was reported out of committee.
- The full House responded in support and the FY 24 Defense Appropriations Act was passed by the House with $20 million dedicated to pancreatic cancer research.
- The House-approved funding increase is for the Pancreatic Cancer Research Program administered through the DoD's Congressionally Directed Medical Research Program (CDMRP).